TESTOVIRON Dépôt sol inj 250 mg i.m. amp 3 pce

7680176260359 CH-17626 G03BA03 07.08.4.
TESTOVIRON Dépôt sol inj 250 mg i.m. amp 3 pce
TESTOVIRON Dépôt sol inj 250 mg i.m. amp 3 pce
TESTOVIRON Dépôt sol inj 250 mg i.m. amp 3 pce
1 / 3
google

Details

Product number
1762602
CPT
-
Packaging group
3 x 250
Unit
mg
Composition
testosteroni enantas 250.000 mg corresp. testosteronum 180 mg, benzylis benzoas, ricini oleum raffinatum 440.000 mg q.s. ad solutionem pro 1 ml.

Articles (1)

Testoviron Depot 250 mg, Injektionslösung
Injektionslösung
3 x 250
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
04/03/2021
Professional SmPC
Français
04/03/2021
Professional SmPC
Italien
04/03/2021

Detailed composition

Substance Quantity Type Category
(N/A)
250.0 MG Substance Wirkstoff (Principe actif)
(N/A)
180.0 MG Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
440.0 MG Substance Wirkstoff (Principe actif)

Authorization holder

Bayer (Schweiz) AG

8045 Zürich

Authorization information

Swissmedic authorization number
17626
Drug name
Testoviron Depot, Injektionslösung
Galenic form
LSPA
ATC Code
G03BA03
Authorization status
Z
Dispensation category
B
First authorization
09/07/1952
Authorization expiration date
31/12/9999
IT number
07.08.4.
Domain
Human medicine
Field of application
Androgenmangel (Hypogonadismus) beim Mann; als Adjuvans bei progressivem Mammakarzinom

Packaging details

Description (FR)
TESTOVIRON Dépôt sol inj 250 mg i.m. amp 3 pce
Description (DE)
TESTOVIRON Depot Inj Lös 250 mg i.m. Amp 3 Stk
Market launch
09/07/1952
Narcotic (BTM)
No

Available generics

Testosteron-Mepha, Injektionslösung
CHF 77.20
View
Testosteron Spirig HC, Injektionslösung
CHF 77.20
View